HARBOUR ANTIBODIES
Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands) for engineering mice to produce high affinity human antibodies. The company has developed two types of human immunoglobulin gene transgenic mice: mice that generate “conventional” tetrameric antibodies comprising two heavy and two light immunoglobulin chains (H2L2); and alternatively, mice that generate heavy chain... only antibodies comprising two immunoglobulin heavy chains with no light chains (HCAbs). Availability of HCAbs facilitates the generation of soluble human VH domains (human heavy chain variable region domains), the minimal immunoglobulin recognition unit, and thus the construction of novel multi-functional molecules comprising either two (or more) VH domains or one VH domain coupled to other molecules. Both Harbour transgenic mouse lines are now available to licensing partners.
HARBOUR ANTIBODIES
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2006-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.harbourantibodies.com
Total Employee:
1+
Status:
Active
Contact:
617.203.2182
Total Funding:
2.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics LetsEncrypt WordPress Google Universal Analytics Apache Wordpress Plugins Euro
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Current Advisors List
Current Employees Featured
Founder
Investors List
Atlas Venture
Atlas Venture investment in Series A - Harbour Antibodies
Official Site Inspections
http://www.harbourantibodies.com Semrush global rank: 9.56 M Semrush visits lastest month: 141
- Host name: 192-254-190-144.unifiedlayer.com
- IP address: 192.254.190.144
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Harbour Antibodies"
Harbour Antibodies - Crunchbase Company Profile
Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at …See details»
Harbour Antibodies B.V. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Harbour Antibodies B.V. of Rotterdam, Zuid-Holland. Get the latest business insights from Dun & …See details»
Harbour Antibodies - Craft
Harbour Antibodies has 5 employees at their 1 location and $3.2 m in total funding,. See insights on Harbour Antibodies including office locations, competitors, revenue, financials, executives, …See details»
About Harbour Antibodies BV
About Harbour Antibodies BV. Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC …See details»
Abveris and Harbour Antibodies H2L2 BV Announce Technology …
Abveris is a premium Boston-area contract research organization specializing in antibody discovery. Abveris partners with large and small biopharmaceutical companies to discover …See details»
Harbour Antibodies U.S., Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Harbour Antibodies U.S., Inc. of Natick, MA. Get the latest business insights from Dun & Bradstreet.See details»
Harbour Antibodies - VentureRadar
Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at Erasmus... ... Find out ...See details»
Harbour Antibodies 2025 Company Profile: Valuation, …
Information on acquisition, funding, cap tables, investors, and executives for Harbour Antibodies. Use the PitchBook Platform to explore the full profile.See details»
Harbour Antibodies Co-Offer | ImmunoPrecise Antibodies
“Harbour’s patented H2L2, fully human transgenic mouse platform has been used globally in many multinational pharma, biotech, non-profit organization and academia, and we are …See details»
Team | Harbour Antibodies BV
Harbour BioMed will give a presentation at PEGS-Boston Conference 2018. April 30th – May 4th, 2018 Seaport World Trade Center Boston, MA Please stop by …See details»
Harbour Antibodies BV: Drug pipelines, Patents, Clinical trials
Explore Harbour Antibodies BV with its drug pipeline, therapeutic area, technology platform, .See details»
Harbour Antibodies BV Raises €2.5M ($3.3M) to Accelerate the ...
Jul 24, 2013 Names BJ Bormann as new CEO. Rotterdam and Cambridge, Massachusetts – July 24, 2013 -- Harbour Antibodies BV, the creator of transgenic mice to aid in the discovery …See details»
HARBOUR ANTIBODIES US INC Newton MA, 02458 - Company …
Free Business profile for HARBOUR ANTIBODIES US INC at 90 Bridge St, Newton, MA, 02458-1119, US. HARBOUR ANTIBODIES US INC specializes in: Commercial Physical and …See details»
Harbour Antibodies BV Raises €2.5M ($3.3M) to Accelerate the ...
“Making these mice available to any research organization, public or private, will help accelerate the discovery of promising new human antibody biopharmaceuticals.” Harbour Antibodies’ …See details»
Harbour Antibodies - Company Information, Competitors, News
Find useful insights on Harbour Antibodies's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Harbour Antibodies.See details»
Harbour Antibodies - VentureRadar
"Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands) for …See details»
Harbour Antibodies - Products, Competitors, Financials, Employees ...
Harbourantibodies.com. Overview & Products; Financials; People; Founded Year 2006. Stage Acquired | Acquired. Total Raised $3.3M. About Harbour Antibodies. Harbour Antibodies is …See details»
Harbour Antibodies | VentureRadar
Website: http://www.harbourantibodies.com. Develops innovative therapeutics for oncology and immunological diseases using patented transgenic mouse platforms, while ...See details»
HBC’s artworks and collections help us understand Canada’s …
7 hours ago Canada’s Cultural Property Export and Import Act alone won’t guarantee that HBC artifacts intended for auction don’t wind up in private collectors’ hands or dispersed globally.See details»
Harbour Antibodies | VentureRadar
Similar Companies: Harbour Biomed China Publicly Traded Harbour BioMed is a global biopharmaceutical company committed to the discovery, development and commercialization …See details»